BusinessTelix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key ExecutivesBy Nasdaq OMXJan 15, 2018, 2:12 AM UTC
BusinessTelix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing PartnershipBy Nasdaq OMXDec 12, 2017, 10:00 PM UTC
BusinessTelix Pharmaceuticals Limited Lists on the Australian Securities ExchangeBy Nasdaq OMXNov 15, 2017, 1:00 AM UTC
BusinessTelix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET TechnologyBy Nasdaq OMXSep 20, 2017, 1:46 AM UTC
BusinessKevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals LimitedBy Nasdaq OMXSep 17, 2017, 10:00 PM UTC
BusinessCyclotek and Telix Pharmaceuticals Conclude Radiopharmaceutical Manufacturing Agreement for Australia and New ZealandBy Nasdaq OMXJul 31, 2017, 4:59 AM UTC
BusinessAdvanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOCBy Nasdaq OMXOct 17, 2016, 11:00 AM UTC
